Journal of Clinical Pharmacy and Therapeutics
Latest Publications

TOTAL DOCUMENTS

3865

(FIVE YEARS 662)

H-INDEX

(FIVE YEARS 8)

Published By Wiley (Blackwell Publishing)

1365-2710, 0269-4727

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Assessment of Anti‐Xa activity in patients receiving concomitant apixaban with strong p‐glycoprotein inhibitors and statins

Journal of Clinical Pharmacy and Therapeutics ◽

10.1111/jcpt.13596 ◽

2022 ◽

Author(s):

Erin Milner ◽

Michael Ainsworth ◽

Melinda Gleaton ◽

David Bookstaver

Keyword(s):

P Glycoprotein ◽

Glycoprotein Inhibitors

Download Full-text

Efficacy of brinzolamide in the initial management of acute primary angle closure: A randomized controlled trial

Journal of Clinical Pharmacy and Therapeutics ◽

10.1111/jcpt.13609 ◽

2022 ◽

Author(s):

Guang Chen ◽

Xinming Peng ◽

Jun Li ◽

Peng Chen ◽

Jing Wang

Keyword(s):

Randomized Controlled Trial ◽

Controlled Trial ◽

Angle Closure ◽

Initial Management ◽

Acute Primary Angle Closure ◽

Randomized Controlled ◽

Primary Angle Closure

Download Full-text

Case report and literature review of BRAF‐V600 inhibitors for treatment of papillary craniopharyngiomas: A potential treatment paradigm shift

Journal of Clinical Pharmacy and Therapeutics ◽

10.1111/jcpt.13600 ◽

2022 ◽

Author(s):

Penelope E. Nussbaum ◽

Leslie A. Nussbaum ◽

Collin M. Torok ◽

Puja D. Patel ◽

Tiffany A. Yesavage ◽

...

Keyword(s):

Case Report ◽

Literature Review ◽

Paradigm Shift ◽

Potential Treatment ◽

Treatment Paradigm

Download Full-text

Clinical outcomes and safety of osimertinib plus anlotinib for patients with previously treated EGFR T790M‐positive NSCLC: A retrospective study

Journal of Clinical Pharmacy and Therapeutics ◽

10.1111/jcpt.13591 ◽

2022 ◽

Author(s):

Bin Zhou ◽

Qiang Gong ◽

Ben Li ◽

Hai‐Ling Qie ◽

Wei Li ◽

...

Keyword(s):

Retrospective Study ◽

Clinical Outcomes ◽

Previously Treated ◽

Egfr T790m

Download Full-text

Potentially inappropriate medications and anticholinergic and sedative burden in older patients with haemophilia or von Willebrand disease: The M’HEMORRH‐AGE study

Journal of Clinical Pharmacy and Therapeutics ◽

10.1111/jcpt.13607 ◽

2022 ◽

Author(s):

Teddy Novais ◽

Christelle Prudent ◽

Amélie Cransac ◽

Frederic Gervais ◽

Christelle Mouchoux ◽

...

Keyword(s):

Older Patients ◽

Von Willebrand Disease ◽

Potentially Inappropriate Medications ◽

Von Willebrand ◽

Inappropriate Medications

Download Full-text

Letermovir and maribavir for pan‐resistant cytomegalovirus infection in a patient with haematologic malignancy: Consideration for combination therapy

Journal of Clinical Pharmacy and Therapeutics ◽

10.1111/jcpt.13585 ◽

2022 ◽

Author(s):

Jana K. Dickter ◽

Justine A. Ross ◽

Jasmine M. Zain ◽

Bernard R. Tegtmeier ◽

Brian V. Lee ◽

...

Keyword(s):

Combination Therapy ◽

Cytomegalovirus Infection

Download Full-text

Analysis of the clinical characteristics of lamotrigine‐induced haemophagocytic lymphohistiocytosis

Journal of Clinical Pharmacy and Therapeutics ◽

10.1111/jcpt.13602 ◽

2022 ◽

Author(s):

Chunjiang Wang ◽

Zhiqiang Fan ◽

Yang He ◽

Weijin Fang ◽

Wei Sun ◽

...

Keyword(s):

Clinical Characteristics ◽

Haemophagocytic Lymphohistiocytosis

Download Full-text

Dramatic clinical response in the treatment of small cell glioblastoma multiforme

Journal of Clinical Pharmacy and Therapeutics ◽

10.1111/jcpt.13608 ◽

2022 ◽

Author(s):

Farzana Yasmin Zaman ◽

Catriona McLean ◽

Malaka Ameratunga

Keyword(s):

Glioblastoma Multiforme ◽

Clinical Response ◽

Small Cell ◽

Small Cell Glioblastoma

Download Full-text

The epidemiology of apnoea of prematurity

Journal of Clinical Pharmacy and Therapeutics ◽

10.1111/jcpt.13587 ◽

2022 ◽

Author(s):

Joseph V. Pergolizzi ◽

Prem Fort ◽

Thomas L. Miller ◽

Jo Ann LeQuang ◽

Robert B. Raffa

Download Full-text

Body mass index and pharmacodynamics of target‐controlled infusion of propofol: A prospective non‐randomized controlled study

Journal of Clinical Pharmacy and Therapeutics ◽

10.1111/jcpt.13594 ◽

2022 ◽

Author(s):

Zijuan Wu ◽

Jinhong Gong ◽

Xiaomei He ◽

Zhouquan Wu ◽

Jingjing Shen ◽

...

Keyword(s):

Body Mass Index ◽

Body Mass ◽

Randomized Controlled Study ◽

Controlled Study ◽

Randomized Controlled ◽

Target Controlled Infusion

Download Full-text

Journal of Clinical Pharmacy and TherapeuticsLatest Publications

TOTAL DOCUMENTS

H-INDEX

Published By Wiley (Blackwell Publishing)

Assessment of Anti‐Xa activity in patients receiving concomitant apixaban with strong p‐glycoprotein inhibitors and statins

Efficacy of brinzolamide in the initial management of acute primary angle closure: A randomized controlled trial

Case report and literature review of BRAF‐V600 inhibitors for treatment of papillary craniopharyngiomas: A potential treatment paradigm shift

Clinical outcomes and safety of osimertinib plus anlotinib for patients with previously treated EGFR T790M‐positive NSCLC: A retrospective study

Potentially inappropriate medications and anticholinergic and sedative burden in older patients with haemophilia or von Willebrand disease: The M’HEMORRH‐AGE study

Letermovir and maribavir for pan‐resistant cytomegalovirus infection in a patient with haematologic malignancy: Consideration for combination therapy

Analysis of the clinical characteristics of lamotrigine‐induced haemophagocytic lymphohistiocytosis

Dramatic clinical response in the treatment of small cell glioblastoma multiforme

The epidemiology of apnoea of prematurity

Body mass index and pharmacodynamics of target‐controlled infusion of propofol: A prospective non‐randomized controlled study

Journal of Clinical Pharmacy and Therapeutics
Latest Publications